I.G. Investment Management’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

I.G. Investment Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-47,643	Closed	-$61K	–	954
2014 Q2	$61K	Hold	47,643	–	–	﹤0.01%	856
2014 Q1	$86K	Sell	47,643 -164,500	-78%	-$278K	﹤0.01%	789
2013 Q4	$331K	Hold	212,143	–	–	﹤0.01%	745
2013 Q3	$515K	Hold	212,143	–	–	﹤0.01%	685
2013 Q2	$610K	Buy	+212,143	New	+$587K	﹤0.01%	656

Other funds holding ONCY

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

I.G. Investment Management's ONCY Position: Q3 2014 in Review

I.G. Investment Management sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2014, closing a stake of 47,643 shares — an estimated $61K sold.

I.G. Investment Management first reported a position in ONCY in Q2 2013 and held it in 5 quarters. The position peaked at $610K in Q2 2013. 30 funds tracked by Wall St. Rank hold ONCY as of Q3 2014.

I.G. Investment Management reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2014 after selling out during the quarter.
I.G. Investment Management sold 47,643 ONCOLYTICS BIOTECH INC shares in Q3 2014, an estimated $61K.
I.G. Investment Management first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 5 quarters.
I.G. Investment Management's ONCOLYTICS BIOTECH INC position peaked at $610K in Q2 2013.
30 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2014.

Based on I.G. Investment Management's 13F filing for Q3 2014, filed 12 Nov 2014.